WallStreetZenWallStreetZen

NASDAQ: TSVT
2seventy Bio Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TSVT past revenue growth

How has TSVT's revenue growth performed historically?
Company
144.26%
Industry
0.69%
Market
13.96%
TSVT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TSVT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TSVT's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TSVT earnings and revenue history

Current Revenue
$124.7M
Current Earnings
-$215.5M
Current Profit Margin
-172.8%

TSVT Return on Equity

Current Company
-61%
Current Industry
41.7%
Current Market
34.8%
TSVT's Return on Equity (-61%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TSVT announces earnings.

TSVT Return on Assets

Current Company
-29.8%
Current Industry
9.3%
TSVT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TSVT Return on Capital Employed

Current Company
-32.38%
Current Industry
14.6%

TSVT vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TSVT$124.69M-$205.21M-$215.46M+144.26%N/A
OGN$6.15B$1.59B$746.00M-0.91%-36.78%
GRFS$6.59B$1.31B$226.39M+4.47%-22.28%
HZNP$3.58B$841.53M$371.91M+27.55%+36.47%
BIIB$10.10B$4.30B$3.13B-4.31%+9.04%
View Top General Drug Manufacturer Stocks

2seventy Bio Earnings & Revenue FAQ

What were TSVT's earnings last quarter?

On Invalid Date, 2seventy Bio (NASDAQ: TSVT) reported Q1 2023 earnings per share (EPS) of -$1.08, up 66.25% year over year. Total 2seventy Bio earnings for the quarter were -$47.02 million. In the same quarter last year, 2seventy Bio's earnings per share (EPS) was -$3.20.

If you're new to stock investing, here's how to buy 2seventy Bio stock.

What was TSVT's earnings growth in the past year?

As of Q2 2023, 2seventy Bio's earnings has grown year over year. 2seventy Bio's earnings in the past year totalled -$215.46 million.

What was TSVT's revenue last quarter?

On Invalid Date, 2seventy Bio (NASDAQ: TSVT) reported Q1 2023 revenue of $41.62 million up 393.78% year over year. In the same quarter last year, 2seventy Bio's revenue was $8.43 million.

What was TSVT's revenue growth in the past year?

As of Q2 2023, 2seventy Bio's revenue has grown 144.26% year over year. This is 143.56 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 0.69%. 2seventy Bio's revenue in the past year totalled $124.69 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.